Phelan J - Search Results

1

Evaluation of recombinant human soluble dimeric tumor necrosis factor receptor for prevention of OKT3-associated acute clinical syndrome.

Eason JD, Pascual M, Wee S, Farrell M, Phelan J, Boskovic S, Blosch C, Mohler KM, Cosimi AB. Eason JD, et al. Among authors: phelan j. Transplantation. 1996 Jan 27;61(2):224-8. doi: 10.1097/00007890-199601270-00011. Transplantation. 1996. PMID: 8600628 Clinical Trial.

2

Effect of mixed hematopoietic chimerism on cardiac allograft survival in cynomolgus monkeys.

Kawai T, Cosimi AB, Wee SL, Houser S, Andrews D, Sogawa H, Phelan J, Boskovic S, Nadazdin O, Abrahamian G, Colvin RB, Sach DH, Madsen JC. Kawai T, et al. Among authors: phelan j. Transplantation. 2002 Jun 15;73(11):1757-64. doi: 10.1097/00007890-200206150-00011. Transplantation. 2002. PMID: 12084998

3

Biological effects and fate of a soluble, dimeric, 80-kDa tumor necrosis factor receptor in renal transplant recipients who receive OKT3 therapy.

Wee S, Pascual M, Eason JD, Schoenfeld DA, Phelan J, Boskovic S, Blosch C, Mohler K, Cosimi AB. Wee S, et al. Among authors: phelan j. Transplantation. 1997 Feb 27;63(4):570-7. doi: 10.1097/00007890-199702270-00015. Transplantation. 1997. PMID: 9047153 Clinical Trial.

4

Association of natural killer cell depletion with induction of mixed chimerism and allograft tolerance in non-human primates.

Kawai T, Wee SL, Bazin H, Latinne D, Phelan J, Boskovic S, Ko DS, Hong HZ, Mauiyyedi S, Nadazdin O, Abrahamian G, Preffer F, Colvin RB, Sachs DH, Cosimi AB. Kawai T, et al. Among authors: phelan j. Transplantation. 2000 Jul 27;70(2):368-74. doi: 10.1097/00007890-200007270-00023. Transplantation. 2000. PMID: 10933165

5

Comparison of horse antithymocyte globulin with other T cell-depleting antibodies for induction of chimerism and renal allograft tolerance in nonhuman primates.

Sogawa H, Kawai T, Wee SL, Boskovic S, Nadazdin O, Phelan J, Abrahamian G, Ko DS, Hong H, Mauiyyedi S, Colvin RB, Sachs DH, Cosimi AB. Sogawa H, et al. Among authors: phelan j. Transplant Proc. 2001 Feb-Mar;33(1-2):116-7. doi: 10.1016/s0041-1345(00)01933-3. Transplant Proc. 2001. PMID: 11266735 No abstract available.

6

Anti-Leu2a (anti-CD8) monoclonal antibody therapy: antibody-mediated cell clearance in vivo requires Fc-FcRII interaction.

Wee SL, Phelan JM, Preffer FI, Colvin RB, Cosimi AB. Wee SL, et al. Among authors: phelan jm. Transplant Proc. 1989 Feb;21(1 Pt 1):117-8. Transplant Proc. 1989. PMID: 2495592 No abstract available.

7

Fc-receptor for mouse IgG1 (Fc gamma RII) and antibody-mediated cell clearance in patients treated with Leu2a antibody.

Wee SL, Colvin RB, Phelan JM, Preffer FI, Reichert TA, Berd D, Cosimi AB. Wee SL, et al. Among authors: phelan jm. Transplantation. 1989 Dec;48(6):1012-7. doi: 10.1097/00007890-198912000-00024. Transplantation. 1989. PMID: 2531948

8

Molecular targets of glucocorticoids that elucidate their therapeutic efficacy in aggressive lymphomas.

Choi J, Ceribelli M, Phelan JD, Häupl B, Huang DW, Wright GW, Hsiao T, Morris V, Ciccarese F, Wang B, Corcoran S, Scheich S, Yu X, Xu W, Yang Y, Zhao H, Zhou J, Zhang G, Muppidi J, Inghirami GG, Oellerich T, Wilson WH, Thomas CJ, Staudt LM. Choi J, et al. Among authors: phelan jd. Cancer Cell. 2024 Apr 25:S1535-6108(24)00131-4. doi: 10.1016/j.ccell.2024.04.007. Online ahead of print. Cancer Cell. 2024. PMID: 38701792

9

Contribution of microglia to the epileptiform activity that results from neonatal hypoxia.

Leavy A, Phelan J, Jimenez-Mateos EM. Leavy A, et al. Among authors: phelan j. Neuropharmacology. 2024 Apr 29:109968. doi: 10.1016/j.neuropharm.2024.109968. Online ahead of print. Neuropharmacology. 2024. PMID: 38692453 Review.

10

Molecular Determinants of Sensitivity to Polatuzumab Vedotin in Diffuse Large B Cell Lymphoma.

Corcoran SR, Phelan JD, Choi J, Shevchenko G, Fenner RE, Yu X, Scheich S, Hsiao T, Morris VM, Papachristou EK, Kishore K, D'Santos CS, Ji Y, Pittaluga S, Wright GW, Urlaub H, Pan KT, Oellerich T, Muppidi J, Hodson DJ, Staudt LM. Corcoran SR, et al. Among authors: phelan jd. Cancer Discov. 2024 Apr 25. doi: 10.1158/2159-8290.CD-23-0802. Online ahead of print. Cancer Discov. 2024. PMID: 38683128

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

791 results

Search Page